This means that whether you choose the arm, thigh, or abdomen, the tirzepatide is working to regulate your appetite and blood sugar
Provider Guidance: Who Should Consider GLP-1 and When GLP-1 agonists may be appropriate for PCOS patients with concurrent obesity, prediabetes, or type 2 diabetes, where metabolic improvement could support hormonal balance
Overcoming Challenges: Because Life Happens Let's face it, even with these wonder drugs, you'll still face challenges
(2017) "Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial" The Lancet Diabetes & Endocrinology, 5(4) This article was reviewed by and approved by Alice Fletcher, Lead Bariatric Dietitian, on 3 April 2025